Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalie Ives

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
AIDS (London, England)|July 20, 2002
The natural history and clinical significance of intermittent viraemia in patients with initial viral suppression to < 400 copies/mlPhilippa J Easterbrook, Natalie Ives, Anele Waters, et al.
The Cochrane Database of Systematic Reviews|November 11, 2011
Helicobacter pylori eradication for Parkinson's diseaseKaren Rees, Rebecca Stowe, Smitaa Patel, et al.
The Cochrane Database of Systematic Reviews|November 11, 2011
Anti-hypertensive drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies and clinical trialsKaren Rees, Rebecca Stowe, Smitaa Patel, et al.
The Cochrane Database of Systematic Reviews|November 11, 2011
Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studiesKaren Rees, Rebecca Stowe, Smitaa Patel, et al.
The Cochrane Database of Systematic Reviews|July 9, 2010
Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson s disease patients with motor complicationsRebecca Stowe, Natalie Ives, Carl E Clarke, et al.
The New England Journal of Medicine|November 3, 2022
Renin-Angiotensin System Inhibition in Advanced Chronic Kidney DiseaseSunil Bhandari, Samir Mehta, Arif Khwaja, et al.
Parkinsonism & Related Disorders|September 12, 2015
Comparing results from long and short form versions of the Parkinson's disease questionnaire in a longitudinal studyCrispin Jenkinson, Carl Clarke, Richard Gray, et al.
JMIR Research Protocols|September 20, 2017
Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled TrialKeira Annie Markey, Ryan Ottridge, James L Mitchell, et al.
The Cochrane Database of Systematic Reviews|June 26, 2018
Botulinum toxins for the prevention of migraine in adultsClare P Herd, Claire L Tomlinson, Caroline Rick, et al.
Health Technology Assessment (Winchester, England)|March 30, 2018
Routine low-dose continuous or nocturnal oxygen for people with acute stroke: three-arm Stroke Oxygen Supplementation RCTChristine Roffe, Tracy Nevatte, Jon Bishop, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
AIDS (London, England)|July 20, 2002
The natural history and clinical significance of intermittent viraemia in patients with initial viral suppression to < 400 copies/mlPhilippa J Easterbrook, Natalie Ives, Anele Waters, et al.
The Cochrane Database of Systematic Reviews|November 11, 2011
Helicobacter pylori eradication for Parkinson's diseaseKaren Rees, Rebecca Stowe, Smitaa Patel, et al.
The Cochrane Database of Systematic Reviews|November 11, 2011
Anti-hypertensive drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies and clinical trialsKaren Rees, Rebecca Stowe, Smitaa Patel, et al.
The Cochrane Database of Systematic Reviews|November 11, 2011
Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studiesKaren Rees, Rebecca Stowe, Smitaa Patel, et al.
The Cochrane Database of Systematic Reviews|July 9, 2010
Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson s disease patients with motor complicationsRebecca Stowe, Natalie Ives, Carl E Clarke, et al.
The New England Journal of Medicine|November 3, 2022
Renin-Angiotensin System Inhibition in Advanced Chronic Kidney DiseaseSunil Bhandari, Samir Mehta, Arif Khwaja, et al.
Parkinsonism & Related Disorders|September 12, 2015
Comparing results from long and short form versions of the Parkinson's disease questionnaire in a longitudinal studyCrispin Jenkinson, Carl Clarke, Richard Gray, et al.
JMIR Research Protocols|September 20, 2017
Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled TrialKeira Annie Markey, Ryan Ottridge, James L Mitchell, et al.
The Cochrane Database of Systematic Reviews|June 26, 2018
Botulinum toxins for the prevention of migraine in adultsClare P Herd, Claire L Tomlinson, Caroline Rick, et al.
Health Technology Assessment (Winchester, England)|March 30, 2018
Routine low-dose continuous or nocturnal oxygen for people with acute stroke: three-arm Stroke Oxygen Supplementation RCTChristine Roffe, Tracy Nevatte, Jon Bishop, et al.
Pageof 9